Page 2 - அமெரிக்கன் நோயியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அமெரிக்கன் நோயியல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அமெரிக்கன் நோயியல் Today - Breaking & Trending Today

Now that there's agreement to invest in innovation, let's make it meaningful


Now that there s agreement to invest in innovation, let s make it meaningful
Nancy Yates, Chief Nursing Informatics Officer, Providence St. Joseph Health and Michelle Woodley, Chief Nursing Informatics Officer, Providence St. Joseph Health
Nancy Yates, Chief Nursing Informatics Officer, Providence St. Joseph Health
Healthcare digital innovation has hit a milestone. No longer are executives questioning “if” they should invest. In fact, in a recent study, more than 75 percent of healthcare executives said digital innovation is key to their long-term strategy. The question now is, “How?”
In a period of policy and financial uncertainty, how do we ensure we have the capacity to make necessary investments? And, perhaps most importantly, how do we ensure investments are clearly meaningful assets to our organization and will truly make a difference in the lives of those we touch? ....

Unalaska Island , United States , Michelle Woodley , Nancy Yates , College Of American Pathology , Joseph Health , Webcam Program , Chief Nursing Informatics Officer , Express Care , California Cancer , American Pathology , California Cancer Registry , Digital Innovation , உணாலஸ்கா தீவு , ஒன்றுபட்டது மாநிலங்களில் , மைக்கேல் வூட்லி , நான்சி யேட்ஸ் , கல்லூரி ஆஃப் அமெரிக்கன் நோயியல் , ஜோசப் ஆரோக்கியம் , வெப்கேம் ப்ரோக்ர்யாம் , தலைமை நர்சிங் தகவல் அதிகாரி , எக்ஸ்பிரஸ் பராமரிப்பு , கலிஃபோர்னியா புற்றுநோய் , அமெரிக்கன் நோயியல் , கலிஃபோர்னியா புற்றுநோய் பதிவு , டிஜிட்டல் கண்டுபிடிப்பு ,

ProPath Appoints Soft Tissue Tumor Expert, Julia A. Bridge, M.D., as Director of Cytogenetics and FISH


Share:
ProPath, the largest fully physician-owned pathology practice in the United States, today announced that Julia A. Bridge, M.D., a board-certified pathologist and geneticist with an extensive medical career and expertise in solid tumor molecular testing, has joined the ProPath team.
Dr. Bridge, who recently directed the Molecular Pathology Research Division at the Translational Genomics Research Institute in Phoenix, AZ, will be directing ProPath s fluorescence in situ hybridization (FISH) and cytogenetics team. She will also be incorporating her testing expertise in bone/soft tissue tumors for ProPath s molecular pathology team.
We are thrilled to have Dr. Bridge join our team, said Cory A. Roberts, M.D., President, Chairman and CEO of ProPath. She has a rare combination of expertise in both anatomic pathology and cytogenetics that make her an expert with an international consultative practice. Her ability to interpret microscopic morphology in concert with h ....

United States , Corya Roberts , University Of Kansas Medical Center , University Of Nebraska Medical Center , Translational Genomics Research Institute , Biomedical Research Institute In Scottsdale Arizona , Children Oncology Group Soft Tissue Sarcoma , College Of American Pathology , Canadian Academy Of Pathology , Glioma Expert Panel , Molecular Pathology Research Division , Nebraska Medical Center , Kansas Medical Center , Southwest Biomedical Research Institute , Oncology Group Soft Tissue Sarcoma , American Pathology , Secretarial Appointee , Tumor Pathology , Soft Tissue , Canadian Academy , ஒன்றுபட்டது மாநிலங்களில் , பல்கலைக்கழகம் ஆஃப் கன்சாஸ் மருத்துவ மையம் , பல்கலைக்கழகம் ஆஃப் நெப்ராஸ்கா மருத்துவ மையம் , மொழிபெயர்ப்பு மரபியல் ஆராய்ச்சி நிறுவனம் , உயிர் மருத்துவ ஆராய்ச்சி நிறுவனம் இல் ஸ்காட்ஸ்டேல் அரிசோனா , குழந்தைகள் புற்றுநோயியல் குழு மென்மையான திசு சர்கோமா ,

This lab is helping fight the STI testing shortage caused by COVID-19


This lab is helping fight the STI testing shortage caused by COVID-19
Share Article
MicroGenDX is a PCR and NGS lab with its own lab developed test (LDT) and is not impacted by the same shortages that are causing delays in STI testing elsewhere.
MicroGenDX Logo
MicroGenDX has over 11 years’ experience designing, and validating laboratory developed tests and mitigating risk in supply chains so that we are able to run the test you need when you need it.
ORLANDO, Fla. (PRWEB)
December 21, 2020
In an era when shortages abound, having options is invaluable. Worldwide, labs are facing a scarcity of supplies, as those needed to test for diseases such as sexually transmitted infections (STIs) must be diverted to Covid-19 testing. Enter MicroGenDX, a company specializing in qPCR + Next Generation Sequencing (NGS) microbial molecular diagnostics.a company that designs and set up its own tests an ....

United States , Nick Sanford , Centers For Disease , College Of American Pathology , Clinical Laboratory Improvement Amendments , College Of American Pathologists , Lab Developed Test , Clinical Laboratory Improvements Amendments , Next Generation Sequencing , Disease Control , Section Director , American Pathology , Prostate Testing , American Pathologists , Polymerase Chain Reaction , Next Generation , ஒன்றுபட்டது மாநிலங்களில் , நிக் சான்ஃபோர்ட் , மையங்கள் க்கு நோய் , கல்லூரி ஆஃப் அமெரிக்கன் நோயியல் , மருத்துவ ஆய்வகம் முன்னேற்றம் திருத்தங்கள் , கல்லூரி ஆஃப் அமெரிக்கன் நோயியல் நிபுணர்கள் , ஆய்வகம் உருவாக்கப்பட்டது சோதனை , மருத்துவ ஆய்வகம் மேம்பாடுகள் திருத்தங்கள் , அடுத்தது ஜெநரேஶந் வரிசைப்படுத்துதல் , நோய் கட்டுப்பாடு ,